Economic burden and quality of life of vulvodynia in the United States
The DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: To explore the economic burden and quality of life of vulvodynia in the United States. METHODS: We conducted a web-based survey from 2009 to 2010. Patients who responded to a National Vulvodynia Association advertisement completed the survey every month, recording their own costs and their employers' payments related to vulvodynia in the previous month. A total of 302 patients entered data for at least 1 month and among them, 97 patients had completed data for 6 months. We used multiple imputation to generate values for unobserved cost components. For insurance payments, we also extracted the average insurance payments for direct healthcare services relating to vulvodynia from a commercial insurance database. The total costs were disaggregated into direct healthcare costs, direct non-healthcare costs and indirect costs. We also assessed patients' quality of life by using Euro QOL 5 dimensions (EQ-5D) in a follow-up survey. RESULTS: The total costs in 6 months were $8862.40 per patient, of which $6043.34 (68.19%) were direct healthcare costs, $553.81 (6.25%) were direct non-healthcare costs and $2265.25 (25.56%) were indirect costs. Based on the reported prevalence range of 3-7% in the US, our analysis yielded an annual national burden ranging from $31 to $72 billion in the US. However, the estimate should be viewed with caution as our study sample was non-probability. The average EQ-5D score was 0.74 ± 0.19 in vulvodynia patients. CONCLUSION: Vulvodynia is associated with a huge economic burden to both individuals and society. It is also related to a relatively low quality of life.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Analysis of Incomplete Multivariate Data
Schafer, J. L. (1997) · doi:10.1201/9781439821862 · Cited by 6,012
EuroQol: the current state of play
Brooks, R. (1996) · Health Policy · doi:10.1016/0168-8510(96)00822-6 · Cited by 5,815
Endometriosis: cost estimates and methodological perspective
Simoens, S., Hummelshoj, L., & D'Hooghe, T. (2007) · Human Reproduction Update · doi:10.1093/humupd/dmm010 · Cited by 357
Arnold, L. D., Bachmann, G. A., Rosen, R., & Rhoads, G. G. (2007) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2006.07.047 · Cited by 185
Pain at the vulvar vestibule: a web-based survey
Reed, B. D., Crawford, S., Couper, M., Cave, C., & Haefner, H. K. (2004) · Journal of Lower Genital Tract Disease · doi:10.1097/00128360-200401000-00011 · Cited by 92
Vulvodynia Incidence and Remission Rates Among Adult Women: A 2-Year Follow-up Study
Reed, B. D., Haefner, H. K., Sen, A., & Gorenflo, D. W. (2008) · Obstetrics & Gynecology · doi:10.1097/aog.0b013e318180965b · Cited by 85
Harlow, B. L., Vazquez, G., MacLehose, R. F., Erickson, D. J., Oakes, J. M., & Duval, S. J. (2009) · Journal of Women s Health · doi:10.1089/jwh.2007.1032 · Cited by 56
Cited by
Vulvodynia: definition, prevalence, impact, and pathophysiological factors
Pukall, C. F., Goldstein, A. T., Bergeron, S., Foster, D., Stein, A., Kellogg-Spadt, S., & Bachmann, G. (2016) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2015.12.021 · Cited by 317
Bergeron, S., Reed, B. D., Wesselmann, U., & Bohm-Starke, N. (2020) · Nature Reviews Disease Primers · doi:10.1038/s41572-020-0164-2 · Cited by 158
Vulvodynia - an evidence-based literature review and proposed treatment algorithm
De Andres, J., Sanchis‐Lopez, N., Asensio‐Samper, J. M., Fabregat‐Cid, G., Villanueva‐Perez, V. L., Monsalve Dolz, V., & Minguez, A. (2016) · Pain Practice · doi:10.1111/papr.12274 · Cited by 127
“have estimated a high financial burden for vulvodynia, with an increased individual and social financial burden and impaired quality of life.(21)”
BackgroundPerceived stereotyping and seeking care for chronic vulvar pain
Nguyen, R. H. N., Turner, R. M., Rydell, S. A., MacLehose, R. F., & Harlow, B. L. (2013) · Pain Medicine · doi:10.1111/pme.12151 · Cited by 92
Brotto, L. A., Bergeron, S., Zdaniuk, B., Driscoll, M., Grabovac, A., Sadownik, L. A., Smith, K. B., & Basson, R. (2019) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2019.04.002 · Cited by 87
Chisari, C., Monajemi, M. B., Scott, W., Moss‐Morris, R., & McCracken, L. M. (2021) · European Journal of Pain · doi:10.1002/ejp.1668 · Cited by 83
“The direct and indirect costs of Vulvodynia in the United States range from 31 to 72 billion dollars annually (Xie et al., 2012).”
BackgroundBrotto, L. A., Zdaniuk, B., Rietchel, L., Basson, R., & Bergeron, S. (2020) · The Journal of Sexual Medicine · doi:10.1016/j.jsxm.2020.07.080 · Cited by 29
Chisari, C., Budhraja, M., Monajemi, M. B., Lewis, F., Moss‐Morris, R., Scott, W., & McCracken, L. M. (2022) · European Journal of Pain · doi:10.1002/ejp.1841 · Cited by 16
“The reported significant diagnostic delay in Vulvodynia (Buchan et al., 2007; Xie et al., 2012) and the reported experiences of invalidation with respect to women's pain in Vulvodynia (Nguyen et al.”
BackgroundJackowich, R. A., Smith, K. B., & Brotto, L. A. (2021) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2020.11.021 · Cited by 10
Buhrman, M., Hällström, H., Fridén, A., Kettis Moden, E., Grahn, G., Carlfjord, M., Hjo, C., Gasslander, N., Bohm‐Starke, N., & McCracken, L. M. (2024) · European Journal of Pain · doi:10.1002/ejp.2253 · Cited by 8
“It is associated with decreased quality of life and high individual and societal costs, estimated at between $31 and $72 billion in the United States (Xie et al., 2012).”
Metadata
- Authors
- Xie, Y., Shi, L., Xiong, X., Wu, E., Veasley, C., & Dade, C.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa Healthcare
- Published
- 2012-03-20
- Volume
- 28
- Issue
- 4
- Pages
- 601-608
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W1990574212
- Cited by
- 105
- References
- 7
- FWCI
- 11.36
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.